返回 Agendas
The Development of Patient Power: From Consumer to Active Participant!
Session Chair(s)
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
Strategy
Consultant, United Kingdom
Collecting views and data directly from patients may provide information which is critical to understanding how medicines are used. The role of patients is changing from simple consumer to being a key part of the drug development program.
Learning Objective : Discuss the importance of patient involvement in developing medicines; Describe how patient involvement can enhance the drug development program; Influence your company to listen to the patient’s voice.
Speaker(s)
Patient-Centric Clinical Trials: What Does It Mean and How Do I Do It?
Joan Meyer
Covance, United States
Collecting Research Data Directly from Consumers: The PROTECT Pregnancy Study
Stella Blackburn, MD, MA, MSc, FFPM, FISPE, FRCP
Consultant, United Kingdom
Strategy
Measuring Patient Engagement and Patient-Centricity
Michael J. Howley, PhD
Drexel University, United States
Chief Scientic Officer, CRO Analytics; Associate Clinical Professor
Patient First Drug Development Across the Product Life Cycle
Sally Okun, BSN, MHS, MBA, RN
Clinical Trials Transformation Initiative (CTTI), United States
Executive Director
注册方法
Registration override should work.